Review article: Methods of measuring gastric acid secretion

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 7, 2011, Pages 768-781

  Ghosh, T ^a   Lewis, D I ^b   Axon, A T R ^a   Everett, S M ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZURESIN; BETAZOLE; CALCIUM CARBONATE; CATION EXCHANGE RESIN; CONGO RED; DYE; GASTRIN; GASTRIN RELEASING PEPTIDE; HISTAMINE; MAGNESIUM; PENTAGASTRIN; PEPSINOGEN; PEPSINOGEN I; PEPSINOGEN II; TETRAGASTRIN;

ACHLORHYDRIA; ALKALINITY; APPLIED POTENTIAL TOMOGRAPHY; ASPIRATION; ATROPHIC GASTRITIS; BREATH ANALYSIS; CHRONIC GASTRITIS; DIAGNOSTIC ACCURACY; DRUG ACTIVITY; DRUG STRUCTURE; DUODENUM ULCER; ENDOSCOPY; GASTRIC PH MONITORING; GASTROINTESTINAL TRACT SCINTISCANNING; HEART PALPITATION; HUMAN; HYDROGEN BREATH TEST; HYPOTENSION; INTERMETHOD COMPARISON; INTESTINE METAPLASIA; INVASIVE PROCEDURE; NAUSEA; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SERUM; SINGLE DRUG DOSE; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH CONTENT; STOMACH PH; STOMACH ULCER; TELEMETRY; TEST MEAL; TOMOGRAPHY; UNSPECIFIED SIDE EFFECT; URINE; ZOLLINGER ELLISON SYNDROME;

DIGESTION; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; HUMANS; HYDROGEN-ION CONCENTRATION; PEPSINOGENS; REPRODUCIBILITY OF RESULTS; STOMACH;

EID: 79952282852     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04573.x     Document Type: Review

References (80)

1. Prout W,. On the nature of acid and saline matters usually existing in stomach of animals. Phil Trans 1824; 114: 45-9.
2. Beaumont W,. Experiments and observations on gastric-juice and physiology of digestion. Nutr Rev 1977; 35: 144-5. (Pubitemid 8136195)
3. Martinsen TC, Bergh K, Waldum HL,. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol 2005; 96: 94-102. (Pubitemid 40320612)
4. Cook GC,. Infective gastroenteritis and its relationship to reduced gastric acidity. Scand J Gastroenterol Suppl 1985; 111: 17-23. (Pubitemid 15105119)
5. Giannella RA, Broitman SA, Zamcheck N,. Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective. Ann Intern Med 1973; 78: 271-6.
6. Sack GH Jr, Pierce NF, Hennessey KN, Mitra RC, Sack RB, Mazumder DN,. Gastric acidity in cholera and noncholera diarrhoea. Bull World Health Organ 1972; 47: 31-6.
7. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB,. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 292: 1955-60. (Pubitemid 39411203)
8. Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006; 117: e817-20. (Pubitemid 46071346)
9. Dial S, Delaney JA, Barkun AN, Suissa S,. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005; 294: 2989-95. (Pubitemid 41817660)
10. Kwiecien S, Konturek SJ,. Gastric analysis with fractional test meals (ethanol, caffeine, and peptone meal), augmented histamine or pentagastrin tests, and gastric pH recording. J Physiol Pharmacol 2003; 54 (Suppl. 3): 69-82. (Pubitemid 41095229)
11. Hitchcock CR,. Screening for gastric cancer. CA Cancer J Clin 1957; 7: 159-61.
12. Metz DC, Starr JA,. A retrospective study of the usefulness of acid secretory testing. Aliment Pharmacol Ther 2000; 14: 103-11. (Pubitemid 30058168)
13. Kay AW,. Effect of large doses of histamine on gastric secretion of HCI; an augmented histamine test. Br Med J 1953; 2: 77-80.
14. Johnston D, Jepson K,. Use of pentagastrin in a test of gastric acid secretion. Lancet 1967; 2: 585-8.
15. Hart Hansen O, Madsen P,. The effect of tetragastrin on gastric acid secretion. Reproducibility and comparison with the pentagastrin test and the augmented histamine test. Scand J Gastroenterol 1972; 7: 171-5.
16. Lawrie JH, Forrest AP,. The measurement of gastric acid. Postgrad Med J 1965; 41: 408-17.
17. Findlay JM, Prescott RJ, Sircus W,. Comparative evaluation of water recovery test and fluoroscopic screening in positioning a nasogastric tube during gastric secretory studies. Br Med J 1972; 4: 458-61.
18. Meeroff JC,. The nomenclature of gastric acid output. Dig Dis Sci 1979; 24: 87-8.
19. Iijima K, Ohara S, Sekine H, et al. A new endoscopic method of gastric acid secretory testing. Am J Gastroenterol 1998; 93: 2113-8. (Pubitemid 29076860)
20. Card WI, Marks IN,. The relationship between the acid output of the stomach following "maximal" histamine stimulation and the parietal cell mass. Clin Sci 1960; 19: 147-63.
21. Drossman DA,. Manual of Gastroenterologic Procedures, 3rd edn. New York: Raven Press, 1992.
22. Ward S, Gillespie IE, Passaro EP, Grossman ML,. Comparison of histalog and histamine as stimulants for maximal gastric secretion in human subjects and in dogs. Gastroenterology 1963; 44: 620-6.
23. Goldenberg J, Cummins AJ, Gompertz ML,. A clinical evaluation of the maximal histalog test. Am J Dig Dis 1967; 12: 468-74.
24. Study MP,. Pentagastrin as a stimulant of maximal gastric acid response in man. A multicentre pilot study. Lancet 1967; 1: 291-5.
25. Konturek PC, Brzozowski T, Kania J, et al. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/reperfusion in rat. Scand J Gastroenterol 2003; 38: 468-76. (Pubitemid 36609849)
26. Schubert ML,. Gastric secretion. Curr Opin Gastroenterol 2008; 24: 659-64.
27. Koster KH, Rodbro P, Petersen HJ,. Comparative effects of tetragastrin and histamine on acid and intransic factor secretion in man. Scand J Gastroenterol 1968; 3: 23-35.
28. Harris AW, Gummett PA, Misiewicz JJ, Baron JH,. Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin. Gut 1996; 38: 663-7. (Pubitemid 26167471)
29. el-Omar E, Penman I, Ardill JE, McColl KE,. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 1995; 36: 534-8.
30. McColl KE, el-Omar E,. Review article: gastrin releasing peptide and its value in assessing gastric secretory function. Aliment Pharmacol Ther 1995; 9: 341-7.
31. Fordtran JS, Walsh JH,. Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. J Clin Invest 1973; 52: 645-57.
32. Halter F, Keller M,. A comparison between intragastric titration and aspiration technique under basal conditions and after food or pentagastrin stimulation. Am J Dig Dis 1978; 23: 723-9. (Pubitemid 8402744)
33. Eisenband RM, Wenger J,. Endoscopic estimate of gastric acid secretion. J Clin Gastroenterol 1981; 3: 287-90. (Pubitemid 11053232)
34. Yamaguchi H, Nakazawa S, Segawa K, Tsukamoto Y,. Precise gastric secretory studies using a new fiber-gastroscope. Hepatogastroenterology 1987; 34: 215-8. (Pubitemid 17147751)
35. Okuda S, Ito T, et al. An Endoscopic Method to Investigate Gastric Acid Secretion. Tokyo: Hitachi Printing, 1966; 221-6.
36. Iijima K, Ohara S, Sekine H, et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000; 46: 20-6. (Pubitemid 30307671)
37. Inomata Y, Koike T, Ohara S, et al. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am J Gastroenterol 2006; 101: 926-33. (Pubitemid 43725303)
38. Abe Y, Ohara S, Koike T, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol 2004; 99: 1213-21. (Pubitemid 39062254)
39. Toth E, Sjölund K, Thorlacius H,. Modified endoscopic Congo red test: a rapid method to visualize gastric acid secretion. Digestive Endoscopy 2003; 15: 7-13. (Pubitemid 36362425)
40. Van Herwaarden MA, Samsom M, Smout AJ,. 24-h recording of intragastric pH: technical aspects and clinical relevance. Scand J Gastroenterol Suppl 1999; 230: 9-16. (Pubitemid 29434504)
41. Fackler WK, Vaezi MF, Richter JE,. Ambulatory gastric pH monitoring: proper probe placement and normal values. Aliment Pharmacol Ther 2001; 15: 1155-62. (Pubitemid 32675449)
42. Cilluffo T, Armstrong D, Castiglione F, et al. Reproducibility of ambulatory gastric pH recordings in the corpus and antrum. Effect of food, time, and electrode position. Scand J Gastroenterol 1990; 25: 1076-83. (Pubitemid 20363205)
43. Hirano I, Richter JE,. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007; 102: 668-85. (Pubitemid 46328165)
44. Fass R, Hell R, Sampliner RE, et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci 1999; 44: 2263-9.
45. Chang JH, Choi MG, Yim DS, et al. A novel placement method of the Bravo wireless pH monitoring capsule for measuring intragastric pH. Dig Dis Sci 2009; 54: 578-85.
46. Banerjee R, Reddy DN,. Bravo capsule pH monitoring. Am J Gastroenterol 2006; 101: 906.
47. Yamaguchi T, Seza A, Odaka T, et al. Placement of the Bravo wireless pH monitoring capsule onto the gastric wall under endoscopic guidance. Gastrointest Endosc 2006; 63: 1046-50. (Pubitemid 43792432)
48. Segal HL, Miller LL, Morton JJ,. Determination of gastric acidity without intubation by use of cation exchange indicator compounds. Proc Soc Exp Biol Med 1950; 74: 218-20.
49. Segal HL, Miller LL, Plumb EJ,. Tubeless gastric analysis with an azure A ion-exchange compound. Gastroenterology 1955; 28: 402-8.
50. Segal HL, Shepardson CR, Plain GL,. Gastric hydrochloric acid secretory response to orally administered betazole hydrochloride. N Engl J Med 1959; 261: 542-4.
51. Bock OA, Witts LJ,. Tubeless gastric analysis with azure a and Betazole hydrochloride. Br Med J 1961; 2: 665-7.
52. Correia JP, de MM,. Tubeless gastric analysis with azure A and maximal histamine stimulation. Br Med J 1963; 1: 365-8.
53. Bolt RJ, Ossius TG, Pollard HM,. A clinical evaluation of tubeless gastric analysis. Gastroenterology 1957; 32: 34-40.
54. Passaro DJ, Hurwitz A, Triadafilopoulos G, Parsonnet J,. A modification of the quininium resin test for assessing gastric acidity. Aliment Pharmacol Ther 2002; 16: 875-80. (Pubitemid 34461755)
55. Noller HG,. Proceedings of the IIIrd International Conference on Medical Electronics. London, 1960; 111.
56. Connell AM, Waters TE,. Assessment of gastric function by Ph telemetering capsule. Lancet 1964; 2: 227-30.
57. Andres MR Jr, Bingham JR,. Tubeless gastric analysis with a radiotelemetering pill (Heidelberg capsule). Can Med Assoc J 1970; 102: 1087-9.
58. Shelton MJ, Akbari B, Hewitt RG, Adams JM, Morse GD,. Eradication of Helicobacter pylori is associated with increased exposure to delavirdine in hypochlorhydric HIV-positive patients. J Acquir Immune Defic Syndr 2000; 24: 79-82. (Pubitemid 30447812)
59. Gritti I, Banfi G, Roi GS,. Pepsinogens: physiology, pharmacology pathophysiology and exercise. Pharmacol Res 2000; 41: 265-81. (Pubitemid 30663131)
60. Samloff IM,. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology 1971; 61: 185-8.
61. Samloff IM, Liebman WM,. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology 1973; 65: 36-42.
62. Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T,. Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects. J Gastroenterol 2005; 40: 938-44. (Pubitemid 41662517)
63. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y,. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003; 98: 735-9. (Pubitemid 36576295)
64. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA,. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44: 693-7. (Pubitemid 29195918)
65. Miki K, Ichinose M, Kawamura N, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989; 80: 111-4. (Pubitemid 20027662)
66. Miki K, Ichinose M, Ishikawa KB, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993; 84: 1086-90. (Pubitemid 23307845)
67. Komoto K, Haruma K, Kamada T, et al. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998; 93: 1271-6. (Pubitemid 29076926)
68. Urita Y, Hike K, Torii N, et al. Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis. Dig Dis Sci 2004; 49: 795-801. (Pubitemid 38870206)
69. Cao Q, Ran ZH, Xiao SD,. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis 2007; 8: 15-22. (Pubitemid 46189205)
70. Sack DA, Stephensen CB,. Liberation of hydrogen from gastric acid following administration of oral magnesium. Dig Dis Sci 1985; 30: 1127-33. (Pubitemid 16132370)
71. Stephensen CB, Leon-Barua R, Sack RB, Sack DA,. Comparison of noninvasive breath hydrogen test for gastric acid secretion to standard intubation test in adults. Dig Dis Sci 1987; 32: 973-7. (Pubitemid 17137978)
72. Humbert P, Lopez de Soria P, Fernandez-Banares F, et al. Magnesium hydrogen breath test using end expiratory sampling to assess achlorhydria in pernicious anaemia patients. Gut 1994; 35: 1205-8. (Pubitemid 24277331)
73. Clough MR, Axon AT,. The Calcium Carbonate Breath Test, a noninvasive test of stimulated gastric acid secretion: preliminary communication. Eur J Gastroenterol Hepatol 2009; 21: 266-72.
74. Taylor TV, Holt S, McLoughlin GP, Heading RC,. A single scan technique for estimating acid output. Gastroenterology 1979; 77: 1241-4. (Pubitemid 10129342)
75. Keane FB, O'Connor M, Stephens RB, Freyne PJ, Hennessy TP,. An assessment of dynamic gastric scanning with 99Tcm-pertechnetate. Br J Surg 1982; 69: 383-5. (Pubitemid 12045411)
76. Baxter AJ, Mangnall YF, Loj EH, et al. Evaluation of applied potential tomography as a new non-invasive gastric secretion test. Gut 1988; 29: 1730-5.
77. Sarker SA, Mahalanabis D, Bardhan PK, et al. Noninvasive assessment of gastric acid secretion in man. Application of electrical impedance tomography (EIT). Dig Dis Sci 1997; 42: 1804-9. (Pubitemid 27394609)
78. Niv Y, Fraser GM,. The alkaline tide phenomenon. J Clin Gastroenterol 2002; 35: 5-8. (Pubitemid 34663342)
79. Rune SJ,. The metabolic alkalosis following aspiration of gastric acid secretion. Scand J Clin Lab Invest 1965; 17: 305-10.
80. Niv Y, Abu-Avid S, Neumann G,. Further applications of blood gas analysis to gastric acidity determination. Clin Chim Acta 1993; 215: 9-19. (Pubitemid 23138508)